newsfilter
← Interviews
Y Combinator53 min

The Future Of Brain-Computer Interfaces

Max Hodak, Garry

Interview, Fireside Chat

Science co-founder Max Hodak outlines a biotechnology roadmap centered on the Prima retinal implant, which has already restored form vision to over 40 patients with macular degeneration, and predicts an imminent "takeoff era" that could enable the first 1,000-year lifespans. Beyond vision restoration, his company is developing bio-hybrid neural interfaces that integrate stem-cell-derived neurons into the brain and portable "Vessel" perfusion systems to revolutionize organ preservation and treat severe disabilities like glaucoma. These initiatives aim to shift healthcare from slow drug discovery to precise neural engineering, potentially achieving high-bandwidth human-AI integration within the next two decades.